Meridian Bioscience Corrects Prior Update Regarding Revogene® SARS-CoV-2 EUA Withdrawal

This corrects the Companys prior statement that the Company would resume shipping the Revogene SARS-CoV-2 test to customers upon notification of its intent to re-submit an EUA application.